Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Clinical Practice Guidelines – Renal Cell Carcinoma

Renal Cell Carcinoma: ESMO Clinical Practice Guidelines

Published in 2019 – Ann Oncol (2019); 30: 706-720.
Authors: B. Escudier, C.Porta, M. Schmidinger, N.Rioux-Leclerq, A. Bex, V. Khoo, V. Gruenwald, S. Gillessen and A. Horwich

Kidney cancer accounts for 5% and 3% of all adult malignancies in men and women, respectively, thus representing the 7th most common cancer in men and the 10th most common cancer in women. These updated ESMO Guidelines provide guidance on the diagnosis, treatment and follow-up of renal cell carcinoma. Recommendations are accompanied by relevant/available supporting evidence and new treatment algorithms.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings